HVAX Technologies Limited — Investor Meet, 26-11-2025: Analysts/Institutional Investor Meet/Con. Call Updates

HVAX Technologies reports H1 FY26 financial results: Total income grew 35% YoY to ₹62.79 Cr, EBITDA rose 19% to ₹8.53 Cr, and net profit increased 29% to ₹4.94 Cr. While margins faced pressure due to project mix and higher sales/marketing investments, a recovery is expected. The company holds a ₹350 Cr order book and a ₹650 Cr pipeline, offering a two-year visibility. Management targets 35% YoY growth for the next couple of years, anticipating a stronger H2 FY26. A key strategic move is the proposed Krew Instruments acquisition, marking HVAX's entry into healthcare infrastructure and offering synergies for global expansion. Human resource development remains a crucial growth focus. Sentiment is confident about sustained, diversified growth.